Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection

Clinical trial NCT04138706 · COMPLETED

Trial details

NCT number: NCT04138706
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Clostridium Difficile Infection

Start date: 2020-11-19
Primary completion: 2024-10-04
Enrollment: 263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.